Orthofix Medical (OFIX) Interest & Investment Income (2013 - 2024)
Orthofix Medical (OFIX) posted Interest & Investment Income of $1.7 million for Q1 2024, up 224.52% on a QoQ basis from -$1.3 million in Q4 2023, and up 2752.38% year-over-year from $58582.6 in Q2 2023.
Orthofix Medical (OFIX) Interest & Investment Income (2013 - 2024) Analysis & Trends
Orthofix Medical's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $1.7 million for Q1 2024.
- Quarterly Interest & Investment Income rose 2752.38% year-over-year to $1.7 million in Q1 2024, while the trailing twelve-month figure through Sep 2024 was $329000.0 (down 71.44% YoY) and the FY2023 annual result came in at -$1.3 million, down 437.72% from the prior year.
- Interest & Investment Income was $1.7 million for Q1 2024 at Orthofix Medical, up from -$1.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.7 million in Q1 2024 and bottomed at -$1.3 million in Q4 2023.
- A 4-year average of -$16153.8 and a median of -$63000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income slumped 217.31% — and 2024, when it jumped 2752.38%.
- Orthofix Medical's Interest & Investment Income stood at -$827000.0 in 2021, then jumped by 238.33% to $1.1 million in 2022, then slumped by 217.31% to -$1.3 million in 2023, then jumped by 224.52% to $1.7 million in 2024.
- Business Quant data shows OFIX's Interest & Investment Income at $1.7 million in Q1 2024, -$1.3 million in Q4 2023, and -$310000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Orthofix Medical | 480.55 Mn | 359.68 Mn | 139.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Sep 30, 2023 | -310,000.00 |
| Jun 30, 2023 | 381,000.00 |
| Mar 31, 2023 | -63,000.00 |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | -236,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | -674,000.00 |
| Dec 31, 2021 | -827,000.00 |
| Sep 30, 2021 | 513,000.00 |
| Jun 30, 2021 | 98,000.00 |
| Mar 31, 2021 | -726,000.00 |
| Mar 31, 2019 | -2.59 Mn |
| Dec 31, 2018 | -1.43 Mn |
| Sep 30, 2018 | 1.24 Mn |
| Jun 30, 2018 | 1.96 Mn |
| Dec 31, 2017 | 7.10 Mn |
| Mar 31, 2017 | -3.22 Mn |
| Dec 31, 2016 | -2.59 Mn |